IA
GH icon

IFP Advisors’s Guardant Health GH Stock Holding History

IFP Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
1,469
+665
+83% +$72.3K ﹤0.01% 1460
2026
Q1 		$74.3K Sell
804
-40
-5% -$4.02K ﹤0.01% 2023
2025
Q4 		$86.2K Buy
844
+217
+35% +$19.4K ﹤0.01% 1886
2025
Q3 		$39.2K Buy
627
+15
+2% +$816 ﹤0.01% 2201
2025
Q2 		$33.2K Buy
612
+334
+120% +$14.9K ﹤0.01% 2268
2025
Q1 		$11.8K Buy
278
+15
+6% +$647 ﹤0.01% 2524
2024
Q4 		$8.03K Buy
263
+7
+3% +$197 ﹤0.01% 2617
2024
Q3 		$5.87K Hold
256
– – ﹤0.01% 2612
2024
Q2 		$7.39K Sell
256
-3,229
-93% -$75.2K ﹤0.01% 2443
2024
Q1 		$71.9K Sell
3,485
-39
-1% -$836 ﹤0.01% 1437
2023
Q4 		$95.3K Sell
3,524
-120
-3% -$3.15K ﹤0.01% 1269
2023
Q3 		$108K Buy
3,644
+12
+0.3% +$422 ﹤0.01% 1216
2023
Q2 		$130K Buy
3,632
+953
+36% +$27.4K 0.01% 1203
2023
Q1 		$86.3K Buy
2,679
+33
+1% +$943 ﹤0.01% 1326
2022
Q4 		$91K Sell
2,646
-112
-4% -$5.13K ﹤0.01% 1801
2022
Q3 		$100K Buy
2,758
+1,180
+75% +$60.6K ﹤0.01% 1856
2022
Q2 		$66K Hold
1,578
– – ﹤0.01% 1964
2022
Q1 		$66K Buy
1,578
+145
+10% +$9.92K ﹤0.01% 1964
2021
Q4 		$147K Sell
1,433
-11
-0.8% -$1.14K ﹤0.01% 1098
2021
Q3 		$184K Sell
1,444
-21
-1% -$2.5K ﹤0.01% 997
2021
Q2 		$183K Sell
1,465
-1
-0.1% -$135 ﹤0.01% 948
2021
Q1 		$226K Buy
1,466
+51
+4% +$7.71K ﹤0.01% 778
2020
Q4 		$183K Buy
1,415
+37
+3% +$4.26K 0.01% 837
2020
Q3 		$155K Sell
1,378
-17
-1% -$1.55K 0.01% 798
2020
Q2 		$113K Buy
1,395
+74
+6% +$5.96K 0.01% 878
2020
Q1 		$93K Sell
1,321
-29
-2% -$2.23K 0.01% 855
2019
Q4 		$107K Buy
1,350
+1,165
+630% +$84K 0.01% 911
2019
Q3 		$11K Buy
+185
New +$16.3K ﹤0.01% 2021

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

IFP Advisors's GH Position: Q2 2026 in Review

IFP Advisors increased its Guardant Health (GH) stake by 83% in Q2 2026, buying an estimated $72.3K and bringing the position to 1,469 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

IFP Advisors first reported a position in GH in Q3 2019 and has held it in 28 quarters since. The position peaked at $226K in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • IFP Advisors held 1,469 shares of Guardant Health worth $220K as of Q2 2026.
  • IFP Advisors bought 665 Guardant Health shares in Q2 2026, an estimated $72.3K.
  • Guardant Health made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1460 holding.
  • IFP Advisors first reported a position in Guardant Health in Q3 2019 and has held it in 28 quarters since.
  • IFP Advisors's Guardant Health position peaked at $226K in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.